A Multiple Dose Trial of NNC 0151-0000-0000 in Subjects With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of this clinical trial is to investigate the
safety, tolerability and pharmacokinetics (at which rate the drug is eliminated from the
body) of NNC 151-0000-0000 in subjects with rheumatoid arthritis (RA).